Synapse - Gregory Riely

Results (607)

EGFR: The paradigm of an oncogene-driven lung cancer

Journal Article

Riely, G. J.; Yu, H. A.
Clinical Cancer Research (2015)

Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib

Journal Article

Naidoo, J.; Sima, C. S.; Rodriguez, K.; Busby, N.; Nafa, K.; Ladanyi, M.; Riely, G. J.; Kris, M. G.; Arcila, M. E.; Yu, H. A.
Cancer (2015)

Fulltext@MSK | Save

A phase I study of twice weekly pulse dose and daily low dose erlotinib as initial treatment for patients (pts) with EGFR-mutant lung cancers

Meeting Abstract

Yu, H. A.; Sima, C. S.; Reales, D.; Jordan, S.; Rudin, C. M.; Kris, M. G.; Michor, F.; Pao, W.; Riely, G. J.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

First-in-human phase I study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor, in advanced non-small cell lung cancer (NSCLC) harboring T790M

Meeting Abstract

Tan, D. S. W.; Seto, T.; Leighl, N. B.; Riely, G. J.; Sequist, L. V.; Felip, E.; Wolf, J.; Yang, J. C. H.; Matushansky, I.; Yu, X. L.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

A phase 1 study of crizotinib and ganetespib (STA-9090) in ALK positive lung cancers

Meeting Abstract

Riely, G. J.; Yu, H. A.; Stephens, D.; Pietanza, M. C.; Smith-Marrone, S.; Fiore, J. J.; Goldstein, M.; Sima, C. S.; Kris, M. G.; Ginsberg, M. S.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Prospective molecular analysis of small cell lung cancer (SCLC) using next generation sequencing (NGS)

Meeting Abstract

Pietanza, M. C.; Won, H. H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Krug, L. M.; Varghese, A. M.; Paik, P. K.; Riely, G. J.; Zakowski, M. F.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Defining the immunologic phenotype of thymic epithelial tumors

Meeting Abstract

Naidoo, J.; Steele, K.; Sima, C. S.; Yuan, J. D.; Robbins, P. B.; Moreira, A. L.; Pietanza, M. C.; Wolchok, J. D.; Riely, G. J.; Rizvi, N. A.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Phase II trial of bortezomib in KRAS G12D mutant lung cancers

Meeting Abstract

Litvak, A. M.; Drilon, A. E.; Rekhtman, N.; Pietanza, M. C.; Chaft, J. E.; Woo, K.; Paik, P. K.; Kris, M. G.; Riely, G. J.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

A phase II, open-label, multicenter study of the ALK inhibitor alectinib in an ALK+ non-small-cell lung cancer (NSCLC) US/Canadian population who had progressed on crizotinib (NP28761)